On March 23, the European Union notified the WTO of the following MRL proposal:

• G/SPS/N/EU/379: Draft Commission Regulation (EU) amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bupirimate, carfentrazone-ethyl, emamectin, ethirimol, and pyriofenone in or on certain products.